Regenexx Logo

NeoStem wins Army contract for wound healing…

By
Published on

NeoStem won an army contract to use topically applied bone-marrow adult mesenchymal stem cells to accelerate would healing. First, NeoStem has had a series of great news, also now working with the Vatican. The Army contact is important, as existing research in humans already shows that mesenchymal stem cells accelerate wound healing, likely through paracrine effects.  This marks a great milestone for adult stem cells, with the Pentagon starting to realize that their potential is the same as embryonic stem cells…

Learn More About Regenexx® Procedures
Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.
We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

TO TOP